Skip to main content
. 2021 Feb 18;9(2):172. doi: 10.3390/vaccines9020172

Table 2.

Clinical characteristics of patients.

Heading Influenza Vaccine 2020 SARS-CoV-2 Vaccine 2020
Unlikely Likely Undecided p-Value Unlikely Likely Undecided p-Value
n (%) n (%) n (%) n (%) n (%) n (%)
Hypertension <0.001 0.078
No 169 (37.5) 180 (39.9) 102 (22.6) 119 (26.5) 172 (38.3) 158 (35.2)
Yes 22 (16.3) 86 (63.7) 27 (20.0) 27 (20.0) 66 (49.9) 42 (31.1)
COPD 0.714 0.360
No 184 (32.2) 261 (45.6) 127 (22.2) 139 (24.4) 236 (41.4) 195 (34.2)
Yes 8 (38.1) 10 (47.6) 3 (14.3) 8 (38.1) 7 (33.3) 6 (28.6)
Diabetes 0.516 0.215
No 185 (33.0) 254 (45.4) 121 (21.6) 135 (24.2) 233 (41.8) 190 (34.0)
Yes (No complications) 6 (20.0) 16 (53.3) 8 (26.7) 11 (36.7) 8 (26.7) 11 (36.7)
Yes (with complications) 1 (33.3) 1 (33.3) 1 (33.3) 1 (33.3) 2 (66.7) 0 (0.0)
Chronic diseases <0.001 0.523
No 114 (40.6) 103 (36.6) 64 (22.8) 74 (26.5) 116 (41.6) 89 (31.9)
Yes 78 (25.0) 169 (54.2) 65 (20.8) 73 (23.4) 127 (40.7) 112 (35.9)
Chronic diseases, number <0.001 0.580
0 118 (41.4) 102 (35.8) 65 (22.8) 76 (26.9) 116 (41.0) 91 (32.2)
1 53 (30.3) 80 (45.7) 42 (24.0) 39 (22.3) 68 (38.9) 68 (38.9)
>=2 25 (18.0) 90 (64.7) 24 (17.3) 34 (24.5) 60 (43.2) 45 (32.4)
Chronic therapy <0.001 0.491
No 127 (41.6) 107 (35.1) 71 (23.3) 81 (26.6) 125 (41.1) 98 (32.2)
Yes 65 (22.7) 163 (57.0) 58 (20.3) 65 (22.8) 118 (41.4) 102 (35.8)

Legend: COPD, chronic obstructive pulmonary disease; ESRD, end stage renal disease.